2-(1,1'-biphenyl-4-yl)-5-chloro-3-methyl-4-quinoline carboxylic acid | 96201-52-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-(1,1'-biphenyl-4-yl)-5-chloro-3-methyl-4-quinoline carboxylic acid
• 英文别名: 2-(1,1'-Biphenyl-4-yl)-5-chloro-3-methyl-4-quinolinecarboxylic acid sodium salt；5-chloro-3-methyl-2-(4-phenylphenyl)quinoline-4-carboxylic acid
• CAS: 96201-52-4
• 化学式: C₂₃H₁₆ClNO₂
• 分子量: 373.839
• InChiKey: ALBQBKQVMVZCOP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(1,1'-biphenyl-4-yl)-5-chloro-3-methyl-4-quinoline carboxylic acid 、 sodium hydroxide 生成 2-(1,1'-biphenyl-4-yl)-5-chloro-3-methyl-4-quinolinecarboxylic acid, sodium salt
  参考文献：
  名称：

  ACKERMAN, NEIL R.;HARRIS, RICHARD R.;LOVELESS, SCOTT E.;NEUBAUER, RUSSEL +

  摘要：

  DOI：
• 作为产物：
  描述：

  4-氯靛红 、 4-丙酰联苯 生成 2-(1,1'-biphenyl-4-yl)-5-chloro-3-methyl-4-quinoline carboxylic acid
  参考文献：
  名称：

  ACKERMAN, NEIL R.;HARRIS, RICHARD R.;LOVELESS, SCOTT E.;NEUBAUER, RUSSEL +

  摘要：

  DOI：

文献信息

• [EN] TREATMENT OF ORGAN TRANSPLANTATION REJECTION
  申请人：THE DU PONT MERCK PHARMACEUTICAL COMPANY

  公开号：WO1991019498A1

  公开（公告）日：1991-12-26

  (EN) 4-Quinoline-carboxylic acid derivatives, such as 2-(2'-fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinoline carboxylic acid, in combination with other immunosuppressive agents are useful for the treatment and/or prevention of transplantation rejection, graft vs. host disease, autoimmune diseases, and chronic inflammatory disease.(FR) Des dérivés d'acide quinoléine-4-carboxylique, par exemple l'acide 2-(2'-fluoro-1,1'-biphényle-4-yle)-6-fluoro-3-méthyle-4-quinoléine carboxylique, associés à d'autres agents immunosuppresseurs, sont utiles au traitement et/ou à la prévention du rejet du greffon, de la réaction du greffon contre l'hôte, des maladies auto-immunes et des affections inflammatoires chroniques.

  4-喹啉羧酸衍生物，例如2-(2'-氟-1,1'-联苯基-4-基)-6-氟-3-甲基-4-喹啉羧酸，与其他免疫抑制剂联合使用可用于治疗和/或预防移植排斥、移植物抗宿主病、自身免疫性疾病和慢性炎症性疾病。
• 4-quinoline carboxylic acid derivatives useful as immunosuppressive
  申请人：The Du Pont Merck Pharmaceutical Company

  公开号：US05084462A1

  公开（公告）日：1992-01-28

  4-Quinolinecarboxylic acids and derivatives thereof, such as 2-(2'-fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid, are useful as immunodulatory and anti-inflammatory agents. Pharmaceutical formulations containing such compounds are useful for the treatment of autoimmune diseases, organ transplantation rejection, graft vs. host disease, multiple sclerosis, and chronic inflammatory diseases such as rheumatoid arthritis.

  4-喹啉羧酸及其衍生物，例如2-(2'-氟-1,1'-联苯-4-基)-6-氟-3-甲基-4-喹啉羧酸，可用作免疫调节和抗炎剂。含有这些化合物的药物制剂可用于治疗自身免疫性疾病、器官移植排斥反应、移植物抗宿主病、多发性硬化症和类风湿性关节炎等慢性炎症性疾病。
• 4-quinoline carboxylic acid derivatives useful for treating skin and
  申请人：E. I. Du Pont de Nemours and Company

  公开号：US04861783A1

  公开（公告）日：1989-08-29

  Phenylquinolinecarboxylic acids and derivatives thereof, such as 2-(2'-Fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid, or a sodium or potassium salt thereof, are useful for the treatment of skin and muco-epithelial diseases.

  苯基喹啉羧酸及其衍生物，例如2-（2'-氟-1,1'-联苯基-4-基）-6-氟-3-甲基-4-喹啉羧酸，或其钠盐或钾盐，可用于治疗皮肤和黏膜上皮疾病。
• Treatment of cancer in mammals by concurrent administration of 4-quinoline carboxylic acid derivatives and interleukin-2
  申请人：E.I. DU PONT DE NEMOURS AND COMPANY

  公开号：EP0362578A1

  公开（公告）日：1990-04-11

  Interleukin-2 (IL-2) in combination with 4-quinoline carboxylic acids and derivatives thereof, such as 2-(2′-fluoro-1,1′-biphenyl-­4-yl)-6-fluoro-3-methyl-4-quinoline carboxylic acid, are useful for the treatment of solid tumors in mammals. The tumor-inhibiting effect of the combination of IL-2 and quinoline carboxylic acids exceeds the effect of either agent alone.

  白细胞介素-2（IL-2）与4-喹啉羧酸及其衍生物（如2-(2'-氟-1,1'-联苯-4-基)-6-氟-3-甲基-4-喹啉羧酸）的组合物，可用于哺乳动物实体瘤的治疗。IL-2和喹啉羧酸的组合物的抑制肿瘤效果超过单独使用任何一种药物的效果。
• 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents
  申请人：THE DU PONT MERCK PHARMACEUTICAL COMPANY

  公开号：EP0339485A1

  公开（公告）日：1989-11-02

  4-Quinolinecarboxylic acids and derivatives thereof, such as 2-(2′-fluoro-1,1′-biphenyl-4-yl)-­6-fluoro-3-methyl-4-quinolinecarboxylic acid, are useful as immunomodulatory and anti-inflammatory agents. Pharmaceutical formulations containing such compounds are useful for the treatment of autoimmune diseases, transplantation rejection, graft vs. host disease, and chronic inflammatory disease such as rheumatoid arthritis.

  4-喹啉羧酸及其衍生物，如 2-(2′-氟-1,1′-联苯-4-基)-6-氟-3-甲基-4-喹啉羧酸，可用作免疫调节剂和抗炎剂。含有此类化合物的药物制剂可用于治疗自身免疫性疾病、移植排斥反应、移植物抗宿主疾病和慢性炎症性疾病，如类风湿性关节炎。